Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to: Conjunctival Biopsy in Ocular Mucous Membrane Pemphigoid.

American journal of ophthalmology·2026
Same author

Ceftazidime for Gram-negative bacterial keratitis.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2026
Same author

Impact of Contact Lens Use on Clinical Profile and Outcomes of Fungal Keratitis: An 8-Year Retrospective Study.

American journal of ophthalmology·2026
Same author

Conjunctival Biopsy in Ocular Mucous Membrane Pemphigoid.

American journal of ophthalmology·2026
Same author

Corneal Perforation Two Years After Mitomycin Intravascular Chemoembolization.

Eye & contact lens·2026
Same author

Risk of raised posterior corneal elevation associated with cornea and sublayer thicknesses 5 years post keratorefractive lenticule extraction.

BMJ open ophthalmology·2026

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K

Pterygium: new insights.

Wai Kit Chu1, Hiu Lam Choi1,2, Amar K Bhat3

  • 1Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Eye (London, England)
|February 8, 2020
PubMed
Summary

Understanding pterygium pathogenesis is key to improving surgical outcomes. Nutlin, an MDM2 antagonist, shows promise as a safer alternative to Mitomycin-C for pterygium treatment.

More Related Videos

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

681
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K
Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

681
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Medicine

Background:

  • Pterygium is a common conjunctival degeneration with unknown pathogenesis.
  • Current treatments like pterygium excision with conjunctival autograft aim to reduce recurrence.
  • Adjuvant therapies have varying success rates and potential adverse effects.

Purpose of the Study:

  • To explore the role of MDM2-p53 interactions in pterygium pathogenesis.
  • To evaluate the potential of MDM2 antagonists, specifically Nutlin, as a safer adjuvant therapy.

Main Methods:

  • Laboratory analysis of pterygium samples.
  • Comparison of Nutlin's toxicity with Mitomycin-C (MMC) in conjunctival cells.

Main Results:

  • Recent research implicates MDM2-p53 interactions in pterygium development.
  • Nutlin demonstrated significantly less toxicity in conjunctival cells compared to MMC.

Conclusions:

  • Targeting the MDM2-p53 pathway presents a novel therapeutic strategy for pterygium.
  • Nutlin offers a potentially safer alternative to existing adjuvant therapies like MMC, warranting further investigation.